[18F]-fluorodeoxyglucose positron emission tomography in patients with suspected recurrence of breast cancer

被引：0
|
作者：
Ehab M. Kamel
Matthias T. Wyss
Mathias K. Fehr
Gustav K. von Schulthess
Gerhard W. Goerres
机构：
[1] University Hospital of Zurich,Division of Nuclear Medicine, Department of Medical Radiology
[2] University Hospital of Zurich,Department of Gynecology and Obstetrics
来源：
Journal of Cancer Research and Clinical Oncology | 2003年 / 129卷
关键词：
Breast cancer; FDG-PET; Recurrence; Tumor marker;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：147 / 153
页数：6
相关论文
共 50 条
  • [1] [18F]-fluorodeoxyglucose positron emission tomography in patients with suspected recurrence of breast cancer
    Kamel, EM
    Wyss, MT
    Fehr, MK
    von Schulthess, GK
    Goerres, GW
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2003, 129 (03) : 147 - 153
  • [2] [18F]Fluorodeoxyglucose positron emission tomography in advanced thyroid cancer
    Taieb, D.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2011, 35 (05): : 329 - 331
  • [3] [18F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in Breast Cancer: When ... and When Not?
    Mankoff, David A.
    Specht, Jennifer M.
    Eubank, William B.
    Kessler, Larry
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (12) : 1252 - 1254
  • [4] [18F] fluorodeoxyglucose-positron emission tomography in patients with medulloblastoma
    Gururangan, S
    Hwang, E
    Herndon, JE
    Fuchs, H
    George, T
    Coleman, RE
    NEUROSURGERY, 2004, 55 (06) : 1280 - 1289
  • [5] Comparison of diagnostic sensitivity of [18F]fluoroestradiol and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for breast cancer recurrence in patients with a history of estrogen receptor-positive primary breast cancer
    Chae, Sun Young
    Son, Hye Joo
    Lee, Dong Yun
    Shin, Eonwoo
    Oh, Jungsu S.
    Seo, Seung Yeon
    Baek, Sora
    Kim, Ji Young
    Na, Sae Jung
    Moon, Dae Hyuk
    EJNMMI RESEARCH, 2020, 10 (01)
  • [6] Comparison of diagnostic sensitivity of [18F]fluoroestradiol and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for breast cancer recurrence in patients with a history of estrogen receptor-positive primary breast cancer
    Sun Young Chae
    Hye Joo Son
    Dong Yun Lee
    Eonwoo Shin
    Jungsu S. Oh
    Seung Yeon Seo
    Sora Baek
    Ji Young Kim
    Sae Jung Na
    Dae Hyuk Moon
    EJNMMI Research, 10
  • [7] Positron emission tomography using [18F]fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer
    Schelling, M
    Avril, N
    Nährig, J
    Kuhn, W
    Römer, W
    Sattler, D
    Werner, M
    Dose, J
    Jänicke, F
    Graeff, H
    Schwaiger, M
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (08) : 1689 - 1695
  • [8] [18F] fluorodeoxyglucose uptake by positron emission tomography for diagnosis of suspected lung cancer -: Impact of verification bias
    Lauer, Michael S.
    Murthy, Sudish C.
    Blackstone, Eugene H.
    Okereke, Ikenna C.
    Rice, Thomas W.
    ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (02) : 161 - 165
  • [9] Standardization of Scanning for [18F] Fluorodeoxyglucose Positron Emission Tomography
    Hanna, Gerard G.
    McAleese, Jonathan
    Lynch, Tom B.
    O'Sullivan, Joe M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (05) : 831 - 832
  • [10] The use of [18F]-fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT) for predicting recurrence in cervical cancer patients
    Brunette, L.
    Mehta, A.
    Lieber, D.
    Bonyadlou, S.
    Lin, Y.
    GYNECOLOGIC ONCOLOGY, 2014, 135 (02) : 389 - 389
12345